Table 4 Fit Proportional Hazard Analysis for all-cause mortality

Age

0.97

0.93–1.02

0.35

BMI

0.97

0.90–1.04

0.43

White

0.70

0.09–5.27

0.73

STS score, mean

1.03

0.94–1.11

0.43

HTN, %

2.83

0.37–21.14

0.23

DM,%

0.76

0.31–1.86

0.55

HLD, %

1.14

0.50–2.62

0.74

Smoking, %

1.72

0.74–3.97

0.19

CVA, %

2.83

1.23–6.49

0.02*

1.85

0.90–3.82

0.09

COPD, %

1.35

0.60–3.03

0.47

CAD, %

1.67

0.68–4.04

0.25

ESRD, %

1.93

0.44–8.35

0.41

PAD, %

1.69

0.74–3.86

0.21

CABG, %

1.09

0.43–2.79

0.86

Cardiac surgery, %

0.97

0.34–2.49

0.95

3 Vessel Disease, %

0.96

0.38–2.44

0.94

ICM (EF < 50%), %

2.23

0.89–5.54

0.10

Angina, %

0.88

0.36–2.14

0.78

Syncope, %

2.28

0.65–7.95

0.24

Creatinine in mg/dl, mean

1.2

0.91–1.54

0.14

FEV1, mean

0.98

0.96–1.01

0.07

eGFR, mean

0.99

0.97–1.01

0.66

Mod -severe MS, %

2.74

0.91–8.24

0.11

Mod-severe AR, %

1.02

0.36–2.85

0.97

Mod-severe MR, %

1.16

0.43–3.14

0.76

Mod-severe TR, %

1.60

0.60–4.27

0.36

LAV, ml

1.00

0.99–1.02

0.13

LAVI, ml/m²

1.00

0.99–1.02

0.36

^#LAAV, ml

1.05

1.01–1.08

0.009*

1.03

1.0–1.01

0.01*

^#LAAVI, ml/m²

1.07

1.0–1.13

0.03*

1.05

1.0–1.01

0.03*

RSPV ostium, cm²

0.85

0.57–1.21

0.39

RIPV ostium, cm²

1.31

0.93–1.78

0.12

LSPV ostium, cm²

0.72

0.45–1.08

0.12

LIPV ostium, cm²

1.12

0.79–1.41

0.45

LVEF

0.98

0.95–1.02

0.42

Mean AV gradient, mmHg

1.01

0.98–1.04

0.49

Aspirin, %

1.20

0.49–2.91

0.67

ACEI/ARBs, %

0.78

0.31–1.98

0.61

Beta blocker, %

0.82

0.30–2.21

0.69

Statins, %

1.14

0.50–2.62

0.74